Cardiovascular magnetic resonance guided electrophysiology studies by Kolandaivelu, Aravindan et al.
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
Journal of Cardiovascular Magnetic 
Resonance
Open Access Review
Cardiovascular magnetic resonance guided electrophysiology 
studies
Aravindan Kolandaivelu, Albert C Lardo and Henry R Halperin*
Address: Johns Hopkins Hospital, Division of Cardiology, Baltimore, MD 21205, USA
Email: Aravindan Kolandaivelu - akoland@jhmi.edu; Albert C Lardo - alardo1@jhmi.edu; Henry R Halperin* - hhalper@jhmi.edu
* Corresponding author    
Abstract
Catheter ablation is a first line treatment for many cardiac arrhythmias and is generally performed
under x-ray fluoroscopy guidance. However, current techniques for ablating complex arrhythmias
such as atrial fibrillation and ventricular tachycardia are associated with suboptimal success rates
and prolonged radiation exposure. Pre-procedure 3D CMR has improved understanding of the
anatomic basis of complex arrhythmias and is being used for planning and guidance of ablation
procedures. A particular strength of CMR compared to other imaging modalities is the ability to
visualize ablation lesions. Post-procedure CMR is now being applied to assess ablation lesion
location and permanence with the goal of indentifying factors leading to procedure success and
failure. In the future, intra-procedure real-time CMR, together with the ability to image complex
3-D arrhythmogenic anatomy and target additional ablation to regions of incomplete lesion
formation, may allow for more successful treatment of even complex arrhythmias without
exposure to ionizing radiation. Development of clinical grade CMR compatible electrophysiology
devices is required to transition intra-procedure CMR from pre-clinical studies to more routine
use in patients.
Introduction
Radiofrequency (RF) catheter ablation has advanced over
the last 25 years from an experimental procedure to the
first line treatment for a number of cardiac arrhythmias
including atrio-ventricular reentrant tachycardia, acces-
sory pathway associated tachycardias, and typical atrial
flutter [1]. These procedures are typically guided by posi-
tioning electrode catheters using x-ray fluoroscopy and
using these catheters to observe the propagation of electri-
cal activity through the heart. Successful targeting of abla-
tion primarily to the anatomic arrhythmia substrate, as
opposed to mapping and targeting ablation based on elec-
trogram characteristics, began with recognition that com-
mon atrial flutter passes through a narrow structure
known as the cavo-tricuspid isthmus [2]. By directing
ablation to interrupt conduction through this region, high
cure rates have been achieved with a low risk of complica-
tions [3].
The clinical indications for anatomy based catheter abla-
tion have since expanded to more complex arrhythmias
such as atrial fibrillation and scar based ventricular tachy-
cardia [4,5]. The basis of these strategies is to target spe-
cific anatomic regions and often to create extended
ablation "lines" by aligning multiple point lesions or by
dragging the catheter along the endocardial surface while
applying ablative energy. While the feasibility of x-ray
fluoroscopy guidance has been demonstrated for these
complex arrhythmias, precise targeting of ablation lesions
is limited by fluoroscopy's inherently poor ability to visu-
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alize cardiovascular soft tissue anatomy. Electrospatial
mapping systems, which locate the catheter tip in 3-D
space relative to magnetic or electric field transmitters,
were rapidly adopted to create surface maps of electrical
characteristics from multiple regions of the heart and
mark the location of ablation attempts so that more elab-
orate ablation patterns could be created (Figure 1a,b).
Electrospatial mapping, however, does not provide direct
visualization of the complex underlying arrhythmogenic
anatomy (Figure 2a,b). The persistence of suboptimal
cure rates, prolonged procedure and radiation exposure
times, and the risk of serious complications have moti-
vated new approaches to facilitate anatomy-based cathe-
ter ablation for complex arrhythmias.
Modern imaging techniques such as Cardiovascular Mag-
netic Resonance (CMR), intra-cardiac ultrasound, and x-
ray computed tomography (CT) are increasingly used to
approach the shortcomings of current mapping and abla-
tion systems. CMR is a particularly flexible imaging
modality that offers excellent soft tissue contrast, well
characterized gadolinium enhancement techniques for
myocardial scar visualization, 3-D imaging of complex
cardiovascular anatomy, real-time 2-D imaging along
arbitrary imaging planes, and the ability to quantify car-
diac motion and blood flow. This article will review the
application of CMR to current clinical procedures and
ongoing advances toward full CMR guidance of electro-
physiology procedures.
The present: Ablation planning and guidance 
using pre-procedural CMR
Atrial fibrillation
CMR has been used most extensively to assist planning
and guidance of atrial fibrillation (AF) ablation proce-
dures. AF is the most common clinically relevant arrhyth-
mia affecting 0.4% of the general population [6]. The
principle morbidities related to AF are stroke due to
embolization of atrial thrombus and symptoms related to
poor heart rate regulation with resting heart rates com-
monly over 110 beats per minute. In the early 1990's sur-
gical modification of the atria with a series of linear
incisions was found to be effective at controlling AF, but a
minimally invasive catheter based procedure could not
replicate these results [7,8]. It was later recognized that the
triggering foci for AF frequently arise from one or more
pulmonary veins (PVs) [9]. The ability to cure AF by ablat-
ing PV triggers or ablating conduction pathways exiting
the PV's was promising but hampered by the risk of pul-
monary vein stenosis due to injury of the vessels [8]. Elec-
Examples of electrospatial mapping guidance of complex arrhythmia ablation Figure 1
Examples of electrospatial mapping guidance of complex arrhythmia ablation. A and B) Electrospatial surface maps 
generated by point-to-point contact mapping of the endocardial surface. The red circles are markers where ablation energy 
was delivered. A) Example of atrial fibrillation ablation in which ablations lesions are placed to encircle the pulmonary veins to 
prevent exit of arrhythmia triggering foci originating from the pulmonary veins. The pulmonary vein locations are marked by 
the colored "cartoon" tubes. B) Example of scar based ventricular tachycardia ablation in which linear lesions were places con-
necting scar (red) to normal tissue (purple) to interrupt the arrhythmia circuit. Figure 1A included with permission from The 
Journal of Cardiovascular Electrophysiology. (Calkins JCEP 2005; 13:53) Figure 1B included with permission from Circulation. 
(Marchlinski, Circ 2000; 101:1288).Journal of Cardiovascular Magnetic Resonance 2009, 11:21 http://www.jcmr-online.com/content/11/1/21
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trospatial mapping technology led to the development of
purely anatomic circumferential ablation strategies in
which circular lesions are created further from the PV ostia
to block the exit of PV triggers [4] (Figure 1a). Using this
technique alone or in combination with PV isolation, a
70% to 80% success rate has been achieved [8]. However,
repeat procedures are often needed to achieve this success
and the success rate drops to 50% or less for the more
chronic forms AF associated with ischemic, hypertensive,
and valvular heart disease [8]. There also remains a 5%
risk of major complications including cardiac perforation,
pulmonary vein stenosis, and the rare but potentially
lethal risk of atrioesophageal fistula formation [8].
In an effort to improve procedural success and reduce
complications, 3-D CMR angiography (MRA) has been
used to assist planning of AF ablation. Kato and col-
leagues used MRA to study left atrial anatomy in normal
subjects and patients with paroxysmal atrial fibrillation
and found that 38% of people had pulmonary vein ana-
tomic variants [10]. Identification of these variants is
important because AF triggering foci can be located within
additional veins (Figure 2a). In addition, ablating near
small or early branching PVs increases the risk of pulmo-
nary vein stenosis [11]. Identification of certain anatomic
variants before the procedure can also assist in catheter
selection or favor using the circumferential ablation
approach which is less affected by variant anatomy. 3-D
imaging may also reduce the risk for complications by vis-
ualizing the relationship of the left atrium to surrounding
structures including the esophagus, descending aorta,
right pulmonary artery, and left circumflex coronary artery
[12-15]. Knowing the location of these structures can be
used to direct placement of ablation lesions to lower risk
areas or guide reduction of ablation power when lesions
are place close to these structures.
Scar based monomorphic ventricular tachycardia
CMR also has the potential to guide the treatment of scar
based monomorphic ventricular tachycardia (MVT), a
potentially lethal arrhythmia that is difficult to treat med-
ically or with current ablation techniques. Ventricular
tachycardia that results in uniform repetitive electrical
activation of the heart arises from anatomically fixed
arrhythmia substrate that can be targeted for ablation.
Myocardial scarring due to infarction, cardiomyopathy,
sarcoidosis, ARVD, or cardiac surgery is a common cause
of MVT [16]. Scar related MVT typically depends on criti-
cal isthmuses of conductive tissue bounded by non-excit-
able scar or a valve annulus [17]. Ablating isthmus
pathways can be curative but identifying the pathways
using traditional mapping techniques can be difficult
because these arrhythmias often lead to hemodynamic
collapse. Substrate based approaches utilizing electrospa-
tial mapping to identify reduced voltage scar border zone
areas and isolated diastolic potentials within low voltage
scar are now being used to identify critical portions of the
arrhythmia circuit to target ablation [5,16] (Figure 1b).
Still, ablation of MVT can be arduous. In addition to
requiring careful point-by-point electrical mapping of the
endocardium, rhythms resulting from epicardial path-
ways may require additional epicardial mapping and
rhythms resulting from intramural pathways may be inac-
cessible to electrical mapping. In addition, procedures
commonly last over six hours to achieve cure rates on the
order of 70% even in the most experienced hands and
success rates can be considerably less in lower volume
centers.
Examples of arrhythmogenic anatomy depicted by CMR Figure 2
Examples of arrhythmogenic anatomy depicted by CMR. A) CMR angiogram anatomy of the pulmonary veins. Note 
that variant pulmonary vein anatomy such as an additional right middle pulmonary vein, indicated by the white arrow, can be 
clearly seen by the CMR. B) The complex structure of myocardial infarction scar, indicated by white arrows, depicted by 
pathology on the left and delayed gadolinium enhanced CMR on the right. Figure 2A included with permission from the Journal 
of Cardiovascular Electrophysiology (Mansour, JCEP 2004; 15:387) Figure 2B included with permission from Circulation (Kim, 
Circ 1999; 100:1992).Journal of Cardiovascular Magnetic Resonance 2009, 11:21 http://www.jcmr-online.com/content/11/1/21
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The use of CMR for assisting MVT ablation is still in the
investigational stages but shows promise. Late gadolin-
ium enhancement CMR (LGE-CMR) has been used exten-
sively to characterize regions of scar in ischemic and non-
ischemic cardiomyopathy (Figure 2b). A number of clini-
cal studies have demonstrated the association of LGE-
CMR scar characteristics such as size, transmurality, and
border-zone area with the risk of MVT [18-20]. Recent
work suggests that high resolution LGE-CMR can be used
to more directly assist in MVT ablation planning. Ashik-
aga and colleagues used an epicardial sock with around
300 electrodes to obtain high-resolution electrical maps
during MVT in a pig infarct model [21]. These maps were
registered to very-high resolution (0.39 × 0.39 × 0.39
mm) ex-vivo LGE-CMR to assess the relationship of MVT
electrical propagation to scar morphology. Detailed scar
imaging revealed numerous previously unseen features
including 3-D tracts of viable myocardium within scar
and scar within viable myocardium that visually corre-
lated with the MVT isthmus identified by electrical activa-
tion mapping. Ciaccio et.al. complimented these findings
by computationally predicting suitable locations for MVT
ablation with the use of high resolution LGE-CMR scar
imaging [22]. Using a model that incorporates regional
scar thickness to estimate MVT excitation wavefront prop-
agation, the MVT circuit isthmus was predicted and
shown to overlap the actual isthmus, observed by electri-
cal mapping, by around 90%. Though these experimental
studies use significantly higher resolution LGE-CMR maps
than the typical 1.5 × 2.5 × 8 mm pixel resolution used
clinically, methods to obtain higher resolution scar
images in patients are being developed and will be dis-
cussed further below [23,24]. Together with studies to
identify safe MR imaging procedures for patients with
implanted defibrillators [25] and clinical correlation of
LGE-CMR scar morphology to successful VT ablation sites,
the role of CMR for clinical VT ablation should be better
defined in the near future.
The current use and limitations of pre-acquired 3D images 
for guiding ablation
The detailed anatomic information available from CMR is
now being used as a roadmap for guiding placement of
ablation lesions [26-30]. A number of techniques have
been developed to register electrospatial mapping catheter
coordinates to pre-acquired 3-D CMR and CT images.
Dong and colleagues recently reported their technique in
patients undergoing AF ablation [30]. They felt that 3-D
imaging was helpful for tailoring ablations to the variant
PV anatomy found in 47% of patients. They also noted
that 3-D images of the atria helped to guide lesion place-
ment in areas where stable catheter positioning was diffi-
cult, such as along the tissue ridge separating the left atrial
appendage from the left pulmonary veins [11,30]. How-
ever, even when guided by 3-D image roadmaps, the study
noted that circumferential ablation around the PVs pre-
vented escape of PV triggers in only 32% of patients [30].
To completely isolate PV triggers, additional electrical
mapping and ablation of specific conduction pathways
was required. Others have created more extensive, riskier
lesions using saline irrigated ablation catheters and still
report PV isolation rates of only 50 to 60% after circum-
ferential ablation around the PVs [31,32].
These sub-optimal results call attention to limitations of
this current state-of-the-art in 3D image guided cardiac
ablation. First, pre-acquired roadmap images may not cor-
respond to the anatomy during the procedure. Changes in
cardiac chamber size associated with variations in heart
rate, rhythm, and volume status are not accounted for by
pre-acquired imaging and could lead to catheter position
registration errors [29]. Additional registration errors can
result from patient motion during the exam, respiratory
motion, and beat-to-beat motion of the heart, including
significant motion of the PVs [33]. Second, marking
attempted ablation positions and confirming reduction in
the local electrogram voltage does not necessarily estab-
lish creation of a permanent ablation lesion or a continu-
ous ablation line [30]. The electrode tissue contact area
and electrode exposure to flowing blood are important
factors in forming adequate ablation lesions [34] but are
poorly assessed by fluoroscopy and electrospatial map-
ping guided procedures. Ablation lesion extent, uninten-
tional gaps in ablation lines, and transient lesion
components such as edema similarly are not well pre-
dicted by current techniques, including intra-cardiac ultra-
sound. These factors limit ablation accuracy and have
been shown to reduce procedure efficacy [35,36].
Intracardiac echocardiography (ICE) addresses some of
these shortcomings and is increasingly used in clinical
practice [37]. ICE has been used to visualize electrode tis-
sue contact, an important factor for efficient ablation
lesion creation. Visualization of microbubbles at the elec-
trode tissue contact interface during ablation has been
also been used to indicate adequate electrode tissue con-
tact while the presence of more coarse bubbles has been
associated with inappropriately high tissue temperatures
that could lead to tissue charring and coagulum forma-
tion. However, ICE has limitations for guiding ablation.
ICE requires invasive placement and manipulation of a
separate imaging catheter and physical limitations on
image plane orientation and field of view limit its ability
to evaluate lesion extent and characterize extended
regions of ablation. Also the ability of ICE to reliably dis-
tinguish regions of ablation from surrounding viable tis-
sue has not been established.
The future: Fully CMR guided EP ablation 
procedures
There are a number of reasons intra-procedure CMR is an
attractive option for guiding future electrophysiology pro-Journal of Cardiovascular Magnetic Resonance 2009, 11:21 http://www.jcmr-online.com/content/11/1/21
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cedures. First, CMR offers a number of ablation lesion
imaging techniques. In addition, the ability to obtain
images in arbitrary orientations opens the potential for
high quality visualization of catheters, anatomy, and elec-
trode tissue contact. Further, the position errors intro-
duced by registering catheter position to pre-acquired 3D
images can be largely avoided because both real-time
CMR images and 3D CMR images are acquired in the
same coordinate system and 3-D images can be reacquired
during the procedure if needed.
Over the last 15 years the basic techniques to enable fully
MR guided EP procedures have been developed. Lardo
and colleagues introduced the potential of CMR for guid-
ing EP procedures in 2000 [38]. Continuous MR imaging
was used to guide non-ferromagnetic EP catheter posi-
tioning from an internal jugular vein to selected locations
in the right atrium and right ventricle. They also demon-
strated the ability to perform and monitor ablations in the
CMR scanner (Figure 3a). Delivery of RF ablation energy
during imaging can cause significant image degradation,
but this noise was dramatically suppressed by 10 MHz
cutoff low-pass filtering of the ablation source. After abla-
tion, imaging at the catheter location showed the lesion
position and extent using both T2 weighted and gadolin-
ium enhanced T1 weighted imaging techniques [38]. The
onset of T2 changes at the ablation site was rapid enough
that it could be used for lesion monitoring shortly after
ablation (Figure 3b).
Subsequent work in our lab has demonstrated the ability
to use real-time CMR to perform basic diagnostic EP stud-
ies [39]. Imaging was performed using an unmodified
clinical scanner with interactive scan plane manipulation
software to guide non-ferromagnetic catheters to standard
electrogram recording sites including the high right
atrium, His bundle, and right ventricular apex. Electrical
interference from gradient switching was adequately sup-
pressed by 30 Hz to 300 Hz bandpass filtering such that
even the low voltage signal from the His bundle could be
identified (Figure 4). Importantly, the study demon-
strated that MR guided electrophysiology measurements
could be performed safely in human subjects. The topic of
device safety in the CMR environment is discussed further
below.
Other techniques relevant to EP procedures have also
been performed using real-time CMR guidance. Trans-
septal catheterization is required for left atrial catheter
ablation. While generally safe, the procedure can be diffi-
cult in the setting of distorted atrial anatomy and carries
the risk of serious complications such as aortic puncture.
The ability of real-time CMR to guide trans-septal punc-
tures under direct visualization of the needle, atria, fossa
ovalis, and surrounding vasculature has been nicely dem-
onstrated [40,41]. Retrograde catheterization of the left
ventricle from the femoral artery is commonly required
for VT ablation and has also been performed under real-
time CMR guidance [42].
Recent advances promise to take MR guided EP from these
initial feasibility studies to safe, efficient practice. These
advances include 1) intra-procedure ablation lesion mon-
itoring techniques, 2) faster 2-D and 3-D imaging, 3)
improved device visualization, 4) intuitive 3-D anatomy
and intracardiac electrogram visualization, and 5) CMR
safe device construction techniques.
Intra-procedure lesion monitoring
Perhaps the most significant advantage of CMR-guided
ablation therapy is the potential to visualize ablation
lesions with high spatial and temporal resolution. The
typical endpoint of current ablation procedures is absence
of electrical conduction across the ablated region and/or
an inability to re-induce the clinical arrhythmia with car-
diac pacing and medications. However, propagation of
electrical signals through the heart is affected by a number
of factors including the tissue temperature change
induced by ablation [43,44]. Some of these factors may be
reversible over time leading to arrhythmia recurrence
[35,36]. As described below, CMR appears capable of
delineating areas permanent tissue damage caused by
ablation. Using CMR lesion imaging to guide ablation
could improve the procedure endpoint from assessment
of potentially transient electrophysiologic changes to a
more direct assessment of complete lines of permanently
damaged tissue in the region of interest.
500 kHz radiofrequency (RF) current is the most com-
monly used ablation source used for electrophysiology
Example of CMR visualization of an ablation catheter posi- tioned at the RV apex a) before and b) after RF ablation Figure 3
Example of CMR visualization of an ablation catheter 
positioned at the RV apex a) before and b) after RF 
ablation. Post ablation images were obtained after periph-
eral injection of gadolinium contrast. Figure included with 
permission from Circulation (Lardo Circ 2000; 102(6):698).Journal of Cardiovascular Magnetic Resonance 2009, 11:21 http://www.jcmr-online.com/content/11/1/21
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procedures. Cryothermy, ultrasound, laser, and micro-
wave ablation are also being investigated. Ablation lesions
can be visualized because CMR is able to detect specific
changes in proton precession and relaxation properties
resulting from heating and heat induced biophysical
changes in cardiac tissue including interstitial edema,
hyperemia, protein conformational changes, cellular
shrinkage, and tissue coagulation [38]. Acute interstitial
edema is likely responsible for the hyperintense region
corresponding to the area of acute RF ablation damage
observed by T2-weighted FSE imaging [38,45] (Figure 5).
Dickfield and colleagues found that this hyperintense
region correlated well with necrotic lesion size on gross
pathology and also noted that gaps between lesions on
imaging corresponded with lesion gaps on pathology
[46]. Lesion visualization by T2 weighted imaging has
been reported as soon as 2 minutes after ablation and sta-
ble imaging characteristics have been observed from 30
minutes to 12 hours post ablation [38,46]. This could
make T2 weighted CMR a tool to evaluate lesions and
lesion continuity over the course of an ablation proce-
dure.
A) Example of the bipolar intracardiac electrograms during scanning before filtering (bottom trace) and after filtering (top  trace) Figure 4
A) Example of the bipolar intracardiac electrograms during scanning before filtering (bottom trace) and after 
filtering (top trace). B) Example of bipolar intracardiac electrograms at various locations in the heart outside the scanner 
(left column) and during scanning with different levels of filtering (right column). RA = Right atrium, His = His bundle, RV = 
right ventricular apex.
Example of non-contrast T2 weighted MR imaging of right ventricular epicardial RF ablation lesions with pathologic correlation Figure 5
Example of non-contrast T2 weighted MR imaging of right ventricular epicardial RF ablation lesions with path-
ologic correlation. Stability of the imaged lesion size is demonstrated from 30 minutes to 12 hours after ablation. Figure 
included with permission from Heart Rhythm (Dickfeld HR 2007;4(2):215).Journal of Cardiovascular Magnetic Resonance 2009, 11:21 http://www.jcmr-online.com/content/11/1/21
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T1 weighted non-contrast enhanced MR imaging of RF
ablation lesions has also been investigated [46]. T1
changes may be related to tissue heating, protein denatur-
ation, and changes in intracellular and extracellular free
water distribution during and following ablation [45-47].
Similar stability of imaging characteristics were reported
from 30 minutes to 12 hours following ablation, though
the lesion contrast by T1 weighted imaging appears to be
less than for T2 weighted imaging [46].
LGE-CMR can provide better visualization of RF ablation
lesions compared with non-contrast imaging techniques
(Figure 6). The time to achieve full enhancement of RF
ablation lesions, one to two hours, is considerably longer
than for DECMR of myocardial infarct scar [48]. However,
good correlation with pathologic lesion size was noted for
intermediate enhancement patterns from one minute to 2
hours after contrast injection, allowing lesion extent to be
assessed without waiting for full enhancement [48]. The 1
to 2 hour interval required for renal clearance between
repeated dosing of gadolinium and the ceiling on total
allowable gadolinium dose limits the use of this tech-
nique for serial lesion assessment during a procedure [45].
Still, gadolinium enhanced imaging may be useful for
evaluating gaps in ablation lines after completion of a
procedure to assess the need to place additional lesions.
Other methods for monitoring ablation lesion formation
during RF energy application are also being investigated.
Proton resonance shift thermography is an CMR tech-
nique that takes advantage of the decrease in the proton
resonance frequency with increasing temperature [49].
This technique has been used to follow tumor ablation in
the uterus, liver, prostate, and brain using diverse energy
sources including RF, high frequency ultrasound, laser,
and microwave [50-55]. Its use for following RF ablation
in the beating heart is being investigated. Current-vector
mapping has also been described for monitoring the
extent of tissue power deposition during RF ablation [56].
While most cardiac ablation lesion CMR studies have
been performed in roughly 10 mm thick ventricle, imag-
ing the less than 3 mm thick human atria is of particular
clinical interest given the difficulty of achieving long term
pulmonary vein isolation following atrial fibrillation
ablation. Peters et.al. demonstrated 3D LGE-CMR of left
Example of gadolinium enhanced T1 weighted MR imaging of right ventricular epicardial RF ablation lesions with pathologic  correlation Figure 6
Example of gadolinium enhanced T1 weighted MR imaging of right ventricular epicardial RF ablation lesions 
with pathologic correlation. Different lesion enhancement patterns are seen from one minute to 2 hours after contrast 
injection. Figure included with permission from the Journal of the American College of Cardiology (Dickfeld JACC 
2006;47(2):370).Journal of Cardiovascular Magnetic Resonance 2009, 11:21 http://www.jcmr-online.com/content/11/1/21
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atrial ablation lesions 10 to 15 minutes after contrast
injection using image based respiratory gating [24]. This
gating technique, also known as respiratory navigator
imaging, allowed higher resolution 3D imaging to be per-
formed without the need for prolonged breath-holding by
tracking diaphragm position on fast 1-D images and col-
lecting 3-D image data within a narrow range of dia-
phragm positions. Current applications have used a
roughly 100 ms mid diastolic acquisition window timed
to precede atrial systole to reduce atrial motion during
imaging. Image resolutions of 1.25 × 1.25 × 2.5 mm
(reconstructed to 0.6 × 0.6 × 1.25 mm) have been demon-
strated. McGann, et.al combined this technique with 3-D
visualization and quantification to assess left atrial scar-
ring before and following atrial fibrillation ablation. They
found that subjects with more than 13% left atrial delayed
enhancement following ablation had a nearly 20 times
higher chance of being free from atrial fibrillation than
those with low amounts of post ablation delayed
enhancement [57]. The technique is now being used to
image immediately following the procedure to target fur-
ther ablation and potentially reduce the need for repeat
procedures. Interestingly, high resolution 3D LGE-CMR
may also be useful for better identifying patients who will
respond poorly to current ablation techniques [58]. Of
note, such high-resolution imaging is not yet feasible in
all patients. In the above studies, imaging took 5 to 10
minutes and 10% to 30% of patients were excluded from
analysis because of poor image quality that was attributed
to patient motion, significant arrhythmia, or incorrect
inversion time selection. Techniques to improve the speed
and reliability of high-resolution CMR require further
investigation.
Faster MR imaging
While cardiac gating can be used to generate MR images
with excellent spatial resolution by splitting data collec-
tion over multiple heartbeats, real-time CMR requires a
more deliberate trade off between temporal and spatial
resolution. To adequately visualize catheters, CMR guided
EP procedures require an in-plane spatial resolution of
around 2 mm2. The target temporal resolution is 7 frames
per second (fps), the usual x-ray fluoroscopy frame rate
for clinical EP procedures.
Since the initial 1 fps imaging used to guide the first MR
guided EP procedure [38] faster, stronger gradients have
increased the temporal resolution capabilities of fast gra-
dient recalled echo sequences to the 5 fps range [59].
Improved gradient performance and B0 field homogene-
ity have also allowed real-time imaging to be performed
with coherent steady state pulse sequences (ie. SSFP, true-
FISP, or FIESTA). These sequences provide increased con-
trast to noise performance at a given frame rate compared
with fast gradient recalled echo sequences [59]. Parallel
imaging techniques can provide additional improvement
in temporal resolution without sacrificing spatial resolu-
tion. These techniques accelerate imaging by covering the
region of interest with multiple receive coils and using the
different spatial sensitivities of these coils to correct for
undersampling of image data [60]. The acceleration
achieved from acquiring less data is countered by the
increased processing time required for estimating coil sen-
sitivities and for performing the parallel reconstruction
[61]. Also, for a given number of receive coils, more
undersampling leads to deteriorating image signal to
noise or a reduced ability to suppress aliasing artifacts
[62]. Balancing these issues, 15 fps true-FISP cardiac imag-
ing with 128 phase encode lines can be performed using
an 8 channel receive coil array and optimized reconstruc-
tion hardware [63]. Commercial CMR systems now com-
monly have multi-channel receivers and parallel imaging
options. The performance of these systems is currently in
the range of what is needed to perform CMR guided EP
procedures at 5 fps with acceptable image quality [61].
While the current imaging rates are adequate for a single
2-D image plane, ideal visualization of the device, target
anatomy, and surrounding reference anatomy may
require multiple 2-D image planes or even 3-D imaging.
Other techniques that can improve imaging speed while
balancing imaging quality include non-Cartesian k-space
sampling, temporal data sharing between images, and
adjusting the tradeoff between temporal and spatial reso-
lution [59]. These techniques may be particularly useful to
accelerate imaging of reference anatomy views that are not
depended on for device tracking. Use of 32 channel
receive arrays to perform more rapid 3-D cardiac imaging
and parallel transmission techniques to permit more effi-
cient parallel data collection are also under active investi-
gation [63-65].
Device Visualization and Navigation
While fluoroscopy provides projection images where the
entire catheter body and tip are easily visualized, 2-D MR
images typically depict a slice through the body that is
around 5 to 10 mm thick. Curved devices such as catheters
may pass in and out of the MR imaging plane leading to
misinterpretation of the device tip position. We have
noted in preclinical studies that poor delineation of the
tip position can result in tissue contact trauma, such as
local hemorrhage. In addition, for electrophysiology abla-
tion procedures the device tip contains the energy source.
Misestimating the tip/tissue contact region can lead to
inaccurate placement of ablation lesions.
During our feasibility studies, tip location has mostly
been performed using interactive real-time sequences
with a user interface that permits adjustment of the scan
plan during image acquisition. Part of the catheter is firstJournal of Cardiovascular Magnetic Resonance 2009, 11:21 http://www.jcmr-online.com/content/11/1/21
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identified on some imaging plane and the plane is manu-
ally adjusted until the tip is located. For vascular proce-
dures where the device is constrained to a co-planar
segment of blood vessel, manual plane manipulation is
acceptable since only minor image plane translations are
needed to visualize the device tip and relevant anatomy.
For navigation in cardiac chambers where the device tip
location is less constrained, the frequent need for manual
plane manipulation necessitates a skilled operator for
image plane manipulation and can distract from efficient
procedure workflow.
One approach to this problem is to automatically direct
imaging to the device location using position sensors
located in the catheter. 15 years ago Dumolin et.al.
described using 1-D projection MR imaging along the x, y,
and z directions to identify the 3-D position of small
receiver coils located in a catheter tip [66]. This position
tracking technique has since been interleaved within real-
time imaging sequences to automatically move the image
plane position to the catheter tip location during device
manipulation [61,67]. While a single tracking coil is suffi-
cient to simply shift the image position, multiple tracking
points are needed to maximize visualization of the device
body or to orient imaging relative to the catheter tip direc-
tion. Multi-coil designs and tracking algorithms have been
developed to reduce the need for separate matching cir-
cuits in space constrained catheter lumens [68,69]. Other
magnetic field and electric field based position finding
techniques have been developed for medical device track-
ing that could also be used for catheter tracking in the
CMR scanner [70-72]. Some of these systems generate
both position and orientation information for each sen-
sor assembly [72,73]. These systems may provide more
accurate and catheter space efficient options for device
tracking. They can also reduce the performance penalty
and avoid the scanner specific complexities associated
with interleaving tracking and real-time imaging
sequences.
An alternative technique for device visualization uses
non-slice selective imaging to produce an effect similar to
projection x-ray fluoroscopy [74,75]. The non-slice selec-
tive catheter imaging plane can be intersected with slice
selective images containing the target anatomy to assist
guidance of the catheter tip. This technique may be used
to provide a "fluoroscopy" view of devices using a number
of catheter antenna designs [69,76-78] (Figure 3a).
Another factor that affects device navigation in the CMR
environment is the physical constraint of performing pro-
cedures near and within the narrow CMR bore. The avail-
ability of shorter, wider bore, high-field CMR scanners are
making this less of an issue. Remote catheter steering is
also gaining interest in the EP field to facilitate point-by-
point electrical mapping of the cardiac chambers and
assist stable device placement during ablation [79,80].
Some of these techniques may be amenable to use in the
CMR environment. A robotic catheter manipulation sys-
tem that uses steerable sheaths with multiple pull wires
was recently used to perform atrial fibrillation ablation in
patients [81]. A magnetic remote steering technique has
also been described that utilizes the torque generated by
current carrying coils in the static CMR magnetic field to
deflect a catheter tip [82,83].
3-D Anatomy and IEGM visualization
The ability to generate real-time images with arbitrary ori-
entations in addition to anatomically detailed 3-D images
with flexible tissue contrast makes CMR well suited for
navigating complex arrhythmia anatomy and delineating
complex ablation patterns. This flexibility also introduces
the potential for disorientation and information over-
load. Appropriate displays and user-interfaces tailored to
the workflow of an EP procedure are needed to manage
this flexibility. Because thin-slice real-time imaging can
intersect anatomy in unfamiliar ways, 3-D visualizations
that plot real-time images oriented relative to reference
images can be helpful (Figure 7). A basic imaging interface
for MR-guided EP procedures would provide a convenient
way to "bookmark" and access reference cardiac views,
switch between real-time and lesion visualization
sequences during the procedure, appropriately present
lesion images for ablation line continuity assessment, and
display the relationship of stored images, catheter posi-
tion, and intracardiac electrograms characteristics in 3-D.
Interventional CMR device safety
The most important consideration for any new diagnostic
or therapeutic approach is safety. While a number of stud-
ies have been performed to determine the safety of con-
ventional CMR with regard to electromagnetic energy
exposure and tissue heating [84,85], interventional proce-
dures add additional considerations and raise new safety
concerns [86-89]. The most straightforward aspect to
CMR device safety is the avoidance of ferromagnetic mate-
rials that could experience significant forces when brought
close to the scanner. Though CMR unsafe objects, such as
ferromagnetic scissors and needle drivers, may be needed
during the preparatory phase of a procedure, until CMR
compatible alternatives are available a system must be in
place to methodically track and remove such objects
before approaching the scanner. The electric current asso-
ciated with defibrillation can also lead to strong displace-
ment forces in high magnetic fields and should be
performed with the defibrillator pads maintained a safe
distance from the scanner bore [90]. Similar attention is
needed to address the ferromagnetic properties and CMR
electromagnetic interference compatibility of other equip-
ment associated with electrophysiology proceduresJournal of Cardiovascular Magnetic Resonance 2009, 11:21 http://www.jcmr-online.com/content/11/1/21
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including physiology monitoring equipment, ablation
and pacing sources, and anesthesia apparatus. Clear mark-
ing of high field areas and secure placement of objects that
may experience magnetic forces is mandatory so that
appropriate pieces of equipment are kept at a safe distance
[91].
An additional safety concern particular to CMR guided
cardiovascular procedures is the significant heating that
can result from RF transmission induced current in
extended metallic objects such as guidewires, wired elec-
trodes, and metal braided catheters [87,88]. This induc-
tion is more pronounced when portions of the device are
located close to the RF transmit body coil housed within
the edge of the scanner bore. Device length is an impor-
tant factor in efficient coupling and heating; however,
many other parameters can influence the sudden onset of
significant heating in the setting of an interventional pro-
cedure [88,92]. The simplest way to avoid this problem is
to construct devices from non-metallic components when
possible. Polymer materials for catheter braiding, such as
Dacron and Kevlar, and composite materials for
guidewires, such as glass fiber reinforced plastics, can be
used to achieve device functional characteristics such as
torqueability, stiffness, and kink resistance [38,93]. Sev-
eral approaches have also been developed to avoid signif-
icant induction heating in structures that require
conductivity. Wires made from high resistance alloys and
gold sputtered thread have been used to obtain intracar-
diac electrograms during imaging with significant reduc-
tion of electrode heating [94]. For structures where
efficient power transfer is required, such as pacing or abla-
tion electrodes, high frequency RF chokes can allow pas-
sage of signal lower than a few MHz while blocking
unwanted MR transmit frequency currents [95,96] A
promising heating suppression technique for position
tracking and intravascular imaging coils that need to pass
differential mode signals at the same frequencies as
unwanted common mode induced currents is to place
thin transmission line transformers in the signal carrying
cables [77,97,98]. Other strategies such as detuning and
decoupling of circuits prone to heating [78,99], fiberoptic
transmission of signals [100], and use of inductively cou-
pled resonators for wireless device tracking [101] are also
considerations for new device design [25,90]. Using sur-
face coils instead of the higher power body coil for RF
transmission has also been proposed as a way to reduce
RF current induction in devices [102]. Now that academic
sites and imaging companies are focusing on heating safe
device development, more rapid progress in this area is
expected.
Example of using automatic catheter highlighting and reference image planes to navigate complex 3-D anatomy using real-time  CMR Figure 7
Example of using automatic catheter highlighting and reference image planes to navigate complex 3-D anat-
omy using real-time CMR. The anatomic location of the catheter position on the image labeled LAX2 is better appreciated 
when overlaid with long and short axis images of the heart. Figure included with permission from The Journal of Magnetic Res-
onance Imaging (Guttman JMRI 2007; 26:1429).Journal of Cardiovascular Magnetic Resonance 2009, 11:21 http://www.jcmr-online.com/content/11/1/21
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Transitioning proof of concept studies to clinical electro-
physiology procedures requires collaboration between
academic centers, imaging and device companies, and reg-
ulatory agencies. The first CMR guided electrophysiology
procedure in a patient was performed using custom cath-
eters made to clinical specifications by a clinical catheter
manufacturer [39]. Prior to use in a human an investiga-
tional device exemption was obtained from the FDA. As
part of this device exemption, catheter heating and reduc-
tion of heating using RF filtering was demonstrated in a
series of device positions and orientations within the
scanner using high SAR imaging protocols [39]. In addi-
tion, safe use of the catheter in animals was documented
prior to human studies. Though catheters with embedded
imaging coils provided improved device visualization in
the animal studies, these devices were not approved for or
used in patients. Before generally applying CMR guidance
to interventional electrophysiology, more standardized
CMR compatible catheter safety guidelines and device
testing protocols need to be developed.
The compatibility of CMR with implanted devices such as
pacemakers and implantable cardiac defibrillators (ICDs)
is also an important consideration in performing inter-
ventional CMR studies in the electrophysiology patient
population. Particular concerns include static magnetic
field induced movement of the device and scanning
induced programming changes, device inhibition, activa-
tion of tachyarrhythmia therapies, and lead currents lead-
ing to heating or cardiac stimulation [103-106]. Modern
devices address some of these concerns with the use of less
ferromagnetic material and improved resistance to elec-
tromagnetic interference [107]. A number of devices have
been carefully studied during in-vitro and animal MR
imaging and experience is growing for safe CMR in
patients with selected devices under controlled scanning
conditions [25,107,108]. This experience includes use of
sequences relevant to modern CMR with SAR characteris-
tics similar to those used for real-time CMR [25]. Still, the
number of patients and devices studied thus far is limited
and further work is needed to develop manufacturer pro-
tocols for establishing conditional CMR safety of pace-
makers and ICDs. Carefully designed protocols for patient
selection, monitoring, and scanning also need to be devel-
oped before imaging of patients with devices can be more
routinely performed. The impact of device related artifacts
on cardiac image interpretation also needs to be more
carefully studied.
Conclusion
Increasing knowledge of the anatomic basis for cardiac
arrhythmias has extended the role of catheter ablation to
curing even complex rhythms such as atrial fibrillation
and scar based ventricular tachycardia. CMR has demon-
strated a number of uses for procedural planning, particu-
larly for treatment of atrial fibrillation. The use of LGE-
CMR for planning VT ablation procedures also shows
promise. Real-time CMR combined with intra-procedural
lesion imaging could allow physicians to accurate guide
devices and establish completeness of ablation lines with-
out concern for radiation exposure. This could signifi-
cantly improve the way current ablation procedures are
performed and open the way to ablative cure of arrhyth-
mias such as permanent atrial fibrillation that currently
respond poorly to minimally invasive approaches [7].
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